iRadimed (IRMD) is an Incredible Growth Stock: 3 Reasons Why Posted byZacks Equity Research February 23, 2022 Leave a comment on iRadimed (IRMD) is an Incredible Growth Stock: 3 Reasons Why iRadimed (IRMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.